AzTrials
AzTrials

Perforated AppendicitisPhase 2PA protocolNCT04039750

Use of Antibiotic Irrigation to Decrease Wound Infections in Pediatric Perforated Appendicitis

A Phase 2 study testing antibiotic rinse with suction and suction only in people with Perforated Appendicitis, run by Prisma Health-Upstate at 1 site in United States.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

The proposed study will investigate whether antibiotic irrigation using a gentamicin/clindamycin solution during laparoscopic appendectomy is superior in preventing postoperative wound infections and IAA in perforated appendicitis compared to suction without irrigation. Read more about this study

Who is it for?
Ages 0 to 18 years
Conditions the study is for
Perforated Appendicitis
What is being tested?
antibiotic rinse with suction and suction only
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
200 participants
Where
1 siteUnited States
Study dates
25 Jul 2019to Dec 2026
Phase
Phase 2
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 0 to 18 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Who may be able to join

  • Male or female, age 18 years or younger
  • Scheduled to undergo laparoscopic appendectomy
  • Preoperative or intra-operative diagnosis of perforated appendicitis (PA).
  • Willingness to undergo treatments, provide written informed consent, and participate in follow-up.

Who cannot join

  • Male or female older than 18 years of age
  • Declined to undergo laparoscopic appendectomy
  • Not willing to provide written informed consent or undergo randomization of treatment
  • Pregnancy

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Prisma Health - Upstate

    Greenville, South Carolina, 29615

Other trials in United States

About this study

The proposed study will investigate whether antibiotic irrigation using a gentamicin/clindamycin solution during laparoscopic appendectomy is superior in preventing postoperative wound infections and IAA in perforated appendicitis compared to suction without irrigation. This will be the first prospective study to compare these two options in pediatric PA.

Read the detailed description

This study is for pediatric patients who are having an appendectomy and have a perforated appendix. The purpose of this study is to see whether antibiotic irrigation using gentamicin, clindamycin and suction during the surgery works better when compared to suction alone when cleaning the stomach cavity.

Arm A patients will have their abdomen irrigated with the antibiotics, gentamycin and clindamycin, and then the wound will be suctioned out. Arm B patients will not have the antibiotic irrigation but will have their wound suctioned.

Being tested
antibiotic rinse with suction, suction only
Medical subject headings
Appendicitis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • antibiotic rinse with suctionDrug

    Also called Clindamycin, gentamycin

    antibiotic rinse with suction

  • suction onlyProcedure or surgery

    no irrigation, suction only

Study groups in NCT04039750
Study groupRoleWhat they receive
Antibiotic irrigation with suctionExperimentalGroup A: You will receive antibiotic irrigation with suction if a PA is found during surgery
Receives: Drug: antibiotic rinse with suction
suction onlyActive comparatorGroup B: You will receive suction alone if a PA is found during surgery
Receives: Procedure: suction only

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. wound complications

    The overall objective is to change the postoperative wound complications and IAA after laparoscopic appendectomy for perforated appendicitis in pediatric patients. The outcome will be measured by tracking any wound complications that these patients have and comparing the incidence between treatment arms

    Measured: 30 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted31 Jul 2019
  2. Study start25 Jul 2019
  3. Primary completionDec 2026 (estimated)
  4. Study completionDec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 2
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Patients will be randomized into 1 of 2 groups. Group "A" will be Antibiotic Irrigation with suction and Group "B" will be Suction Alone.
Masking
Single blind
Who is masked
Participant
Enrolment
200 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04039750
Sponsor's protocol ID
Pro00088360
Acronym
PA protocol
Status last verified
Jan 2026
First submitted
26 Jul 2019
Last updated
27 Jan 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
Yes
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A Phase 2 study testing antibiotic rinse with suction and suction only in people with Perforated Appendicitis, run by Prisma Health-Upstate at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 27 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

wound complications (time frame: 30 days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Jan 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in